HolderBook

Opus Point Partners Management, LLC

Reported holdings as of Q3 2019, from 4 quarterly filings.

This filer last reported in Q3 2019; the most recent quarter on file across all filers is Q2 2026. Firms that restructure stop filing under one CIK and start under another, so a successor entity may hold these positions now under a similar name.

CIK
1600175
Reported value
$55.3M
Positions
54
Top 10 weight
64.3%
Filed
2019-11-14
Days after quarter end
45

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
ISHARES TR OPTIBB$20.9M125,00037.76%+3.86pp4qHELD
DIREXION SHS ETF TRLABUXXXX$3.1M99,8555.58%-1.73pp4q+1.4%+$44.0K
METTLER TOLEDO INTERNATIONALMTD$2.3M3,2354.12%+0.10pp4qHELD
BRISTOL-MYERS SQUIBB COBMY$1.7M33,0003.02%+0.81pp3qHELD
SEATTLE GENETICS INCSGENXXXX$1.5M18,0202.78%+0.95pp4q+0.7%+$10.2K
ILLUMINA INCILMN$1.4M4,7212.59%+0.04pp4qHELD
VERTEX PHARMACEUTICALS INCVRTX$1.4M8,2792.54%+0.31pp4q+1.0%+$14.6K
IONIS PHARMACEUTICALS INCIONS$1.2M20,1242.18%+0.27pp4qHELD
ALNYLAM PHARMACEUTICALS INCALNY$1.1M13,6841.99%+0.55pp4q+2.5%+$26.8K
ALEXION PHARMACEUTICALS INCALXN$973.0K9,9331.76%-0.17pp4qHELD
QIAGEN NVQGEN$951.0K28,8581.72%-0.01pp4qHELD
SPARK THERAPEUTICS INCONCE$941.0K9,6991.70%+0.23pp3qHELD
FORTRESS BIOTECH INCFBIO$865.0K613,5511.56%+1.04pp4q+162.2%+$535.1K
PROQR THRAPEUTICS N VPRQR$798.0K138,4611.44%-0.42pp4qHELD
INCYTE CORPINCY$791.0K10,6591.43%+0.09pp4qHELD
EXACT SCIENCES CORPEXAS$771.0K8,5341.39%-0.10pp3qHELD
REGENERON PHARMACEUTICALSREGN$677.0K2,4391.22%+0.20pp4q+9.8%+$60.5K
BIOMARIN PHARMACEUTICAL INCBMRN$654.0K9,7001.18%-0.01pp4q+3.2%+$20.2K
DECIPHERA PHARMACEUTICALS INDCPH$632.0K18,6311.14%+0.52pp3qHELD
ASCENDIS PHARMA A/SASND$596.0K6,1901.08%+0.02pp3qHELD
UNIQURE NVQURE$560.0K14,2151.01%-0.63pp3qHELD
CELGENE CORPCELG$559.0K5,6251.01%+0.24pp4qHELD
CRISPR THERAPEUTICS AGCRSP$542.0K13,2140.98%+0.06pp3qHELD
EPIZYME INCEPZM$520.0K50,3780.94%flat3qHELD
AMARIN CORP PLCAMRNXXXX$510.0K33,6410.92%+0.44pp3q+102.2%+$257.7K
BLUEPRINT MEDICINES CORPBPMC$498.0K6,7800.90%-0.05pp3qHELD
AUDENTES THERAPEUTICS INCBOLD$487.0K17,3390.88%-0.09pp3qHELD
G1 THERAPEUTICS INCGTHX$475.0K20,8440.86%-0.09pp3qHELD
GLOBAL BLOOD THERAPEUTICS INGBT$460.0K9,4790.83%+0.09pp3qHELD
BIOHAVEN PHARMACTL HLDG CO LBHVNXXXX$453.0K10,8520.82%+0.12pp3qHELD
ARENA PHARMACEUTICALS INCARNA$447.0K9,7700.81%-0.04pp3qHELD
ACADIA PHARMACEUTICALS INCACAD$432.0K12,0050.78%+0.31pp4qHELD
GW PHARMACEUTICALS PLCGWPH$423.0K3,6740.76%-0.17pp3qHELD
ZOGENIX INCZGNX$389.0K9,7250.70%+0.01pp3qHELD
MACROGENICS INCMGNX$384.0K30,0750.69%-0.06pp3qHELD
INTELLIA THERAPEUTICS INCNTLA$380.0K28,4900.69%flat3qHELD
BIO-TECHNE CORPTECH$303.0K1,5510.55%+0.07pp4qHELD
IQVIA HLDGS INCIQV$297.0K1,9850.54%+0.06pp4qHELD
AMGEN INCAMGN$294.0K1,5180.53%+0.15pp4q+8.7%+$23.4K
NEUROCRINE BIOSCIENCES INCNBIX$282.0K3,1270.51%+0.13pp4q+3.8%+$10.4K
CHECKPOINT THERAPEUTICS INCCKPT$281.0K112,7600.51%flat4qHELD
CHARLES RIV LABS INTL INCCRL$280.0K2,1120.51%+0.06pp4qHELD
UNITED THERAPEUTICS CORP DELUTHR$279.0K3,4980.50%-newNEW
GRIFOLS S AGRFS$264.0K13,1960.48%+0.07pp4qHELD
BIOGEN INCBIIB$261.0K1,1230.47%+0.08pp2qHELD
INTERCEPT PHARMACEUTICALS INICPT$261.0K3,9260.47%-0.22pp4q-33.1%-$129.4K
GILEAD SCIENCES INCGILD$259.0K4,0820.47%+0.06pp4qHELD
LIGAND PHARMACEUTICALS INCLGND$242.0K2,4280.44%+0.08pp3q+15.0%+$31.6K
NEKTAR THERAPEUTICSNKTR$235.0K12,9270.42%-0.23pp4q+3.4%+$7.7K
EXELIXIS INCEXEL$232.0K13,1320.42%+0.06pp4q+14.8%+$29.9K
ALKERMES PLCALKS$227.0K11,6320.41%-newNEW
ULTRAGENYX PHARMACEUTICAL INRARE$217.0K5,0640.39%-0.08pp4qHELD
FIBROGEN INCFGEN$212.0K5,7420.38%+0.06pp4q+17.6%+$31.7K
RECRO PHARMA INCSCTL$126.0K11,3530.23%+0.06pp4qHELD

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 37.7%Not classified 62.3%
 
SectorValueShare
Biotech & Pharma$20.9M37.7%
Not classified$34.5M62.3%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q3 2019$55.3M5421411064.3%45
Q2 2019$67.6M6211411359.8%45
Q1 2019$73.8M7437525257.5%45
Q4 2018$45.4M39000074.5%45

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.